We’re filling the gaps in mental healthcare.

Kintsugi is the art of repairing fractures in ceramics with gold. What once was broken becomes stronger and more beautiful. We bring this philosophy to strengthening mental wellness infrastructures. So instead of falling through the cracks, more people can embrace their flaws and find beauty in their growth.

Kintsugi was built from a solid foundation.

A software engineer and a machine learning scientist, two ambitious women, shared a common challenge in accessing quality mental health services through their healthcare providers. They decided to put their strengths together to create something that could improve their lives, the lives of their families, and the lives of billions around the world.

In October of 2019, Kintsugi was awarded a Phase I grant for developing new AI technology by the National Science Foundation. Since then, the Bay Area team has received a number of accolades and distinctions for their AI technology, Kintsugi Voice, which detects signs of clinical depression and anxiety from short clips of free-form speech.


Kintsugi is made up of passionate individuals united by a desire to improve access to mental healthcare. We hope to embody the change we create by being generously loving to ourselves, those we love, and those who need love.

Product Advisory board

David B. Nash, MD, MBA

Founding Dean Emeritus at Jefferson College of Population Health

David B. Nash is the Founding Dean Emeritus, and remains on the full-time faculty as the Dr. Raymond C. and Doris N. Grandon Professor of Health Policy, at JCPH.

A board-certified internist, Dr. Nash is internationally recognized for his work in public accountability for outcomes, physician leadership development, and quality-of-care improvement. More recently, he has achieved wide acclaim for his Covid19 thought leadership and served as the Chief Health Advisor for the Philadelphia Convention and Visitor’s Bureau (PHL-CVB) for the duration of the pandemic. Dr. Nash is a principal faculty member for quality of care programming for the American Association for Physician Leadership (AAPL). Dr. Nash has governance responsibilities for organizations in the public and private sectors. He has chaired the Technical Advisory Group (TAG) of the Pennsylvania Health Care Cost Containment Council (HC4) for more than 25 years and he is widely recognized as a pioneer in the public reporting of outcomes. Dr. Nash has been a hospital trustee for 20 years. He now serves on the board of the Geisinger Commonwealth School of Medicine (GCSOM); AMGA Foundation; and the Commission on Accreditation of Healthcare Management Education (CAHME). In the for-profit sector, he serves on the advisory board of InfoMC, MaxHealth, Capital Partners, ANI Pharmaceuticals, and Fox Rehab. Dr. Nash’s work is well known through his many publications, public and virtual appearances, and online column on MedPage Today. He has authored more than 100 peer-reviewed articles and edited 25 books, including The Quality Book, Demand Better, and most recently his best selling book, How Covid Crashed the System: A Guide to Fixing American Healthcare. He is currently Editor-in-Chief of the American Journal of Medical Quality and Population Health Management. Dr. Nash received his BA in economics (Phi Beta Kappa) from Vassar College; his MD from the University of Rochester School of Medicine and Dentistry and his MBA in Health Administration (with honors) from the Wharton School at the University of Pennsylvania. While at Penn, he was a former Robert Wood Johnson Foundation Clinical Scholar and Medical Director of a nine-physician faculty group practice in general internal medicine. He has received honorary doctorates from Salus University in Philadelphia, GCSOM, and the University of Rochester. Dr. Nash has delivered a score of endowed and named lectures across the country and has given more than 15 commencement addresses.

David B. Nash, MD, MBA

Founding Dean Emeritus at Jefferson College of Population Health

Donald Jones

TDV Operating Partner, Takeda Pharmaceuticals; Founder & Chair IMPACT Virtual First Healthcare

Donald Jones has over two decades of experience as a founder, independent Board Member or Advisory Board member of numerous companies.

Donald works in a balance of VC & Private Equity backed companies and Fortune 1000 companies. His expertise is in applied technology enabling mobility, connectivity and network effect in healthcare and value based solutions. He works across digital medicine, digital therapeutics, digital health, virtual first care and digital transformation and has extensive C suite operating background in EMS (COO of largest company in the world, with 29,000 paramedics, growing to $2.5B), emergency medicine (formed the largest medical group in the US with 25,000 physicians, growing to $2.5B), house calls, telemedicine, urgent care, M&A and big data predictive analytics. Donald is the Founder and Chair of the largest private practice in Mexico, a business built around consumer subscriptions. He has built Qualcomm's Wireless Health Group and has collaborated over the past decade with Eric Topol, MD, Director of Scripps Research Translational Institute (SRTI) to found the West Health Institute and Scripps Digital Medicine, a leading clinical trials program in the field, and a Masters program in Digital Medicine for physicians. SRTI holds the largest NIH grant in history as part of the 'All of Us' Precision Medicine Initiative.

Donald Jones

TDV Operating Partner, Takeda Pharmaceuticals; Founder & Chair IMPACT Virtual First Healthcare
Kintsugi voices

Perspectives on mental health trends


At Kintsugi, we are looking to scale access to mental healthcare for everyone in need by developing objective, quantifiable, and accurate measurements to raise the parity of mental health to that of physical health.

Grace Chang

Founder / CEO